Tratamiento sistémico en la enfermedad oligometastásica - page 19

GETUG-12. PFS pacientes alto riesgo: ADT vs ADT+DE
1...,9,10,11,12,13,14,15,16,17,18 20,21,22,23,24,25,26,27,28,29,...31
Powered by FlippingBook